These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2202352)
1. Discrimination between HIV-1 and HIV-2-seropositive individuals using mouse monoclonal antibodies directed to HIV transmembrane proteins. Hunt JC; Johnson-Paepke J; Boardway K; Gutierrez R; Hampl H; Allen R; Heynen C; Desai S; Casey J; Tribby I AIDS Res Hum Retroviruses; 1990 Jul; 6(7):883-98. PubMed ID: 2202352 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2. Carpio E; Duarte C; Hinkula J; Broliden PA; Rosén J; Campal A; Gavilondo J; Wahren B; Jondal M AIDS Res Hum Retroviruses; 1991 Jan; 7(1):97-101. PubMed ID: 1707645 [TBL] [Abstract][Full Text] [Related]
3. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein. Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of a mouse monoclonal antibody (5-21-3) employed as a competitive probe in an immunoassay to detect antibody to HIV-1 gp41. Hunt JC; Falk L; Webber JS; Decker RH; Devare SG; Dawson GJ AIDS Res Hum Retroviruses; 1990 May; 6(5):599-606. PubMed ID: 1694452 [TBL] [Abstract][Full Text] [Related]
5. Production and characterization of a mouse monoclonal antibody against the Gag p26 protein of human immunodeficiency virus type 2: identification of a new antigenic epitope. Marcelino JM; Novo C; Pereira JM; Picotez F; Clemente A; Taveira N AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1279-83. PubMed ID: 11559428 [TBL] [Abstract][Full Text] [Related]
6. Relevance of the reactivity of HIV 1 positive sera with synthetic peptides for understanding antigenic differences between circulating strains. Cernescu C; Ruţă SM Rev Roum Virol; 1993; 44(3-4):175-86. PubMed ID: 7826868 [TBL] [Abstract][Full Text] [Related]
7. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA. Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841 [TBL] [Abstract][Full Text] [Related]
8. Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides. Blomberg J; Vincic E; Jönsson C; Medstrand P; Pipkorn R AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1363-72. PubMed ID: 2127683 [TBL] [Abstract][Full Text] [Related]
9. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera. Schneider T; Harthus HP; Hildebrandt P; Niedrig M; Bröker M; Weigelt W; Beck A; Pauli G AIDS Res Hum Retroviruses; 1991 Jan; 7(1):37-44. PubMed ID: 1707640 [TBL] [Abstract][Full Text] [Related]
10. Production and characterization of mouse monoclonal antibodies against the transmembrane protein of a human immunodeficiency virus type 2. Komatsu H; Yamashita A; Tozawa H; Mizutani Y; Honda M; Kawamura M; Hayami M AIDS Res Hum Retroviruses; 1991 Dec; 7(12):999-1005. PubMed ID: 1725959 [TBL] [Abstract][Full Text] [Related]
11. Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1. Norrby E; Putkonen P; Böttiger B; Utter G; Biberfeld G AIDS Res Hum Retroviruses; 1991 Mar; 7(3):279-85. PubMed ID: 1712215 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of synthetic peptides for the detection of antibodies against human immunodeficiency virus]. Lottersberger J; Salvetti JL; Tonarelli G Rev Argent Microbiol; 2003; 35(3):149-55. PubMed ID: 14587377 [TBL] [Abstract][Full Text] [Related]
13. Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2. Niedrig M; Hinkula J; Harthus HP; Bröker M; Hopp L; Pauli G; Wahren B J Virol; 1991 Aug; 65(8):4529-33. PubMed ID: 1712863 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens. Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41. Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986 [TBL] [Abstract][Full Text] [Related]
16. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Kang CY; Luo L; Wainberg MA; Li Y Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338 [TBL] [Abstract][Full Text] [Related]
17. Competition ELISA using a human monoclonal antibody for detection of antibodies against human immunodeficiency virus type 1. Bugge TH; Hansen LL; Lindhardt BO; Kvinesdal B; Kusk P; Holmbäck K; Hulgaard E; Ulrich K J Virol Methods; 1991 Apr; 32(1):1-10. PubMed ID: 1712361 [TBL] [Abstract][Full Text] [Related]
18. Multiple antigenic epitopes expressed on gag proteins, p26 and p15, of a human immunodeficiency virus (HIV) type 2 as defined with a library of monoclonal antibodies. Komatsu H; Tozawa H; Kawamura M; Kodama T; Hayami M AIDS Res Hum Retroviruses; 1990 Jul; 6(7):871-81. PubMed ID: 1697178 [TBL] [Abstract][Full Text] [Related]
19. Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infection. Shafferman A; Lennox J; Grosfeld H; Sadoff J; Redfield RR; Burke DS AIDS Res Hum Retroviruses; 1989 Feb; 5(1):33-9. PubMed ID: 2541748 [TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide. Ota A; Tanaka-Taya K; Ueda S Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]